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Abstract
Introduction and hypothesis—Our objective was to evaluate bowel symptoms after
colpocleisis.
Methods—This was a planned ancillary analysis of a prospective, colpocleisis cohort study of
152 women. Those with baseline and 1-year questionnaires (Colorectal-Anal Distress Inventory
(CRADI) and the Colorectal-Anal Impact Questionnaire (CRAIQ)) were included. “Bothersome”
CRADI symptoms (score>2(“moderately”, “quite a bit”)) were identified. CRADI and CRAIQ
scores were compared, and postoperative symptom resolution and new symptom development
were measured.
Results—Of 121 (80%) subjects with complete data, mean age was 79.2±5.4 years and all had
stage 3–4 prolapse. Procedures performed: partial colpocleisis (61%), total colpocleisis (39%),
levator myorrhaphy (71%), and perineorrhaphy (97%). Bothersome bowel symptom(s) were
present in 77% at baseline (obstructive (17–26%), incontinence (12–35%) and pain/irritation (3–
34%)). All bothersome obstructive and most bothersome incontinence symptoms were less
prevalent 1 year after surgery. CRADI and CRAIQ scores significantly improved. The majority of
bothersome symptoms resolved (50–100%) with low rates of de novo symptoms (0–14%).
Conclusions—Most bothersome bowel symptoms resolve after colpocleisis, especially
obstructive and incontinence symptoms, with low rates of de novo symptoms.
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Introduction
Pelvic floor disorders, including urinary incontinence, fecal incontinence, and pelvic organ
prolapse (POP) are present in 23.7% of women in the USA and may increase with advanced
age [1]. In the USA, surgery for POP and other pelvic floor disorders have increased in the
last decade [2,3]. While most prolapse surgeries restore and maintain vaginal coital function,
higher risk patients with advanced age, medical comorbidities, extensive surgical history,
and/or those not interested in maintaining coital function may be better served with a
colpocleisis. Potential benefits of colpocleisis include its minimally invasive technique
(superficial incisions without entry into the peritoneal cavity), high success rate [4],
relatively short operating time, low blood loss, and ease of recovery.
As part of a multicenter, cohort study that evaluated the effects of colpocleisis on pelvic
organ support, pelvic symptoms, and quality of life, women with an age range of 65 to 94
years reported improved satisfaction, as well as improved bowel symptoms, 1 year after
colpocleisis [4]. Other studies have also reported improved bowel symptoms after other
surgical treatments for POP. Sacrocolpopexy was found to improve both anal incontinence
and obstructed defecation one year after surgery [5]. Another randomized controlled trial
showed similar symptom improvement in bowel symptoms after two types of rectocele
repair, with the most improvement observed for obstructive symptoms of straining and
incomplete emptying [6].
More data is needed about the relationship of colpocleisis and specific bowel symptoms,
such as fecal incontinence and obstructed defecation. Although the primary report from the
above cohort study of women undergoing colpocleisis [4] revealed a general postoperative
improvement in bowel symptoms, changes in individual bowel symptoms were not
described. The purpose of this analysis was to study change in bothersome bowel symptoms
after colpocleisis for the same cohort of women with advanced age. Specifically, we sought
to determine rates of resolution of existing symptoms and development of new symptoms.
We hypothesized that bothersome bowel symptoms would improve after colpocleisis with
the most improvement observed for obstructive symptoms and less improvement for
incontinence and pain/irritation symptoms.
Materials and methods
This was a planned ancillary analysis of bowel symptoms among women enrolled in a
multicenter prospective, cohort study of 152 women undergoing total and partial (LeFort)
colpocleisis [4]. The colpocleisis cohort study was performed through the Pelvic Floor
Disorders Network (PFDN), a cooperative network sponsored by the Eunice Kennedy
Shriver National Institute of Child Health and Human Development. Informed consent and
institutional review board approval was obtained by individual PFDN sites.
Study patients underwent colpocleisis to surgically correct stages 3 and 4 POP. The type of
colpocleisis (total or partial (LeFort)) as well as concomitant procedures such as
perineorrhaphy, levator myorrhaphy, and/or incontinence surgery were performed at the
discretion of the surgeon. Surgeons preserved the distal 3 to 4 cm of the anterior vaginal
epithelium caudad to the urethrovesical junction. Total colpocleisis was defined as removal
of all proximal anterior and posterior vaginal epithelium cephalad to the urethrovesical
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junction. Partial (LeFort) colpocleisis was defined as partial removal of the proximal
anterior and posterior vaginal epithelium cephalad to the urethrovesical junction creating a
longitudinal vaginal septum with bilateral vaginal epithelium tunnels. Data collection and
methods have been published [4]. Baseline data collection included a Pelvic Organ Prolapse
Quantification (POP-Q) exam [7], body mass index (BMI; kilograms per square meter),
sociodemographic data, medical history, and surgical history (prior prolapse repair and
hysterectomy). Bowel symptoms were evaluated at baseline and one year postoperative
using validated quality-of-life measures including the Colorectal-Anal Distress Inventory
(CRADI) and the Colorectal-Anal Impact Questionnaire (CRAIQ) [8].
The CRADI, a subscale of the Pelvic Floor Distress Inventory (PFDI), contains 16 questions
that evaluate the presence of bowel symptoms and related bother. The CRADI has four
subscales: obstructive, incontinence, pain/irritation, and rectal prolapse. Respondents are
asked whether they experience each symptom, and if so, how much the symptom bothered
them on a scale of 1 (not at all) to 4 (quite a bit). CRADI subscale scores range from 0 to
100 with higher scores indicating more severe symptom bother. The CRADI composite
score is the sum of the four subscale scores and ranges from 0 to 400. The CRAIQ, a
subscale of the Pelvic Floor Impact Questionnaire (PFIQ), measures the impact of bowel
symptoms on 31 activities of daily living. Responses range from 1 (“not at all”) to 4 (“quite
a bit”). The CRAIQ score ranges from 0 to 400 with higher scores indicating more severe
functional impairment.
In order to describe the effect of colpocleisis on “bothersome” bowel symptoms, we defined
the presence of individual “bothersome” CRADI symptoms as the presence of a symptom
and a bother >2 (“moderately” or “quite a bit”). Bothersome symptoms were compared at
baseline and 1 year after colpocleisis. Resolution of a bothersome baseline symptom at 1
year was defined as the absence of the symptom at 1 year after surgery or a bother score of
≤2 (“not at all” or “somewhat”). Development of a de novo bothersome symptom was
defined as an absent baseline symptom or a CRADI score ≤2 preoperatively in a patient who
recorded a score of >2 at 1 year postoperative. We also compared baseline and 1 year
postoperative CRADI composite scores, CRADI subscale scores, and CRAIQ scores. In a
subgroup of women who underwent levator myorrhaphy, we compared the resolution of
bothersome bowel symptoms, the development of de novo bothersome symptoms, and the
change in CRADI composite scores, CRADI subscale scores, and CRAIQ scores from
baseline to 1 year after surgery. We also compared the effects of each type of colpocleisis
(total or partial (LeFort)) on bowel symptom resolution and CRADI scores.
Continuous variables (age, BMI) were described using means and standard deviations (SD).
Bowel symptoms were described using dichotomous variables (CRADI individual
questions) and continuous variables (CRADI composite, CRADI subscales, and CRAIQ).
Since the bowel symptoms with continuous scales were severely skewed to the right, they
were described by median and interquartile range (IQR). To compare the presence of
bothersome bowel symptoms at baseline and 1 year postoperative, we used McNemar's test
for dichotomous data and Wilcoxon's signed-rank test for continuous data. Resolution of
bothersome symptoms and de novo bothersome symptoms among groups were analyzed
using Wilcoxon's scores test and Wilcoxon's signed-rank test. A p value of ≤0.05 was
considered statistically significant.
In order to assess the magnitude of change in CRADI and CRAIQ composite and subscale
scores, we calculated the group effect size for each score change. This measure evaluates
change in relation to sample variation, providing a means of demonstrating that change has
occurred and of presenting that change in a standardized metric [9]. The effect size was
calculated as the change in mean score divided by the SD of the baseline score [10].
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The sample size for this ancillary analysis was determined by the number of subjects
enrolled in the original study (152), and was limited by the number of women that had
complete baseline and 1 year postoperative CRADI and CRAIQ questionnaires.
Results
One hundred fifty-two patients enrolled in the colpocleisis cohort study, of whom 121 (80%)
completed both baseline and 1-year questionnaires. Clinical and demographic characteristics
of subjects with complete data (Table 1) were similar to those without complete data with
respect to sociodemographics, prior medical history, POP-Q stage, and baseline bowel
symptoms.
As detailed in Table 2, at least one bothersome bowel symptom was present in 77% of
subjects at baseline, including obstructive symptoms (17–26%), incontinence symptoms
(12–35%) and pain/irritation symptoms (3–34%). All bothersome obstructive and most
bothersome incontinence symptoms were less prevalent 1 year after surgery with the
exception of fecal incontinence of solid stool (p=0.23). While the prevalence of three of the
pain/irritation symptoms (fecal urgency, mucus with bowel movements, and hemorrhoids)
was lower postoperatively, the prevalence of the remaining four symptoms (low back pain,
pain prior to bowel movements, pain with defecation, and pain with straining) was not
significantly different.
Detailed in Table 3, the CRADI composite scores, CRADI subscale scores, and CRAIQ
scores were all significantly lower (p<0.01) 1 year after colpocleisis indicating an overall
improvement in all aspects of bowel symptoms. The greatest improvement was observed in
the CRADI composite score and the CRADI obstructive and incontinence subscale scores in
comparison to the CRADI pain/irritation subscale score and CRAIQ score. The effect sizes
for the CRADI composite, CRADI-obstructive, CRADI-incontinence, CRADI-pain/
irritation and CRAIQ score changes were 0.48, 0.53, 0.42, 0.31, and 0.33, respectively.
Presented in Table 4, bothersome bowel symptoms resolved in the majority of subjects (50–
100% for each symptom) with low rates of de novo bothersome symptoms (0–14%).
Concomitant levator myorrhaphy influenced neither the resolution of bothersome bowel
symptoms nor the development of de novo symptoms with one exception: de novo
incomplete bowel emptying did not develop in any of the women who had a myorrhaphy but
developed in three (11%) that did not undergo myorrhaphy (p=0.03).
At baseline and 1 year, there were no differences in CRADI composite scores, CRADI
subscale scores, and CRAIQ scores between the women who had levator myorrhaphy and
those that did not undergo myorrhaphy (data not included.) Also, bowel symptom resolution,
CRADI composite score, and CRADI subscale scores were not significantly different
between the total and partial (LeFort)) colpocleisis subjects.
Discussion
This secondary analysis from a prospective observational study demonstrates that
bothersome colorectal symptoms are common in older women with stages 3–4 prolapse, and
that most symptoms improve after colpocleisis with perineorrhaphy. All bothersome
obstructive symptoms and almost all incontinence symptoms were less prevalent after
surgery, and the development of new bothersome bowel symptoms was uncommon.
Little data has been previously published on bowel function after colpocleisis. Barber et al.
[11], reported improvements in overall CRADI and CRAIQ scores in 30 women followed-
up 1 year after colpocleisis. The bowel symptom changes seen by Barber et al. and
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reproduced here in a larger cohort of women are similar to improvements reported after both
abdominal and vaginal reconstructive prolapse surgeries, despite an older study population
in the colpocleisis cohorts [5,6,11]. It is reassuring that bowel symptoms improve with
surgical procedures that correct severe apical support defects (sacrocolpopexy), posterior
compartment defects (rectocele repair), and global support defects involving all
compartments (colpocleisis).
This study adds to the literature by providing detail about colorectal symptom subtypes and
individual symptom changes after colpocleisis. Among the CRADI subscales, the
obstructive and incontinence symptom scores demonstrated the greatest improvement. All
individual bothersome obstructive and incontinence symptoms (except incontinence of solid
stool) were significantly less frequent after surgery. While the pain-irritation symptom
subscale demonstrated modest score improvement overall, changes in individual pain-
irritation symptoms were more variable, perhaps because these symptoms may more often
result from underlying bowel disorders rather than from POP. Persistent bothersome bowel
symptoms after colpocleisis that do not respond to medical management can be evaluated
using techniques such as colonoscopy, dynamic MRI, defecography, and anal manometry.
Levator myorrhaphy or plication is performed routinely with colpocleisis by many surgeons
to reduce the genital hiatus, although to our knowledge, no comparative study exists to
support or refute this practice. As previously published, in this prospective cohort study,
anatomic success did not differ by levator myorrhaphy [4]. Similarly, we did not find
substantial differences in individual bowel symptom resolution or in new symptom
development in those women who did or did not have levator myorrhaphy with colpocleisis,
but we caution that our power to compare these groups was limited. Furthermore, since
levator myorrhaphy was not performed in a randomized fashion, measured and unmeasured
differences between the groups may have existed at baseline, limiting our ability to compare
their outcomes. Reassuringly, in the larger group who had concurrent levator myorrhaphy,
CRADI (total and subscale), and CRAIQ score changes all significantly improved after
surgery, suggesting that this procedure when performed with colpocleisis is not associated
with detrimental outcomes in terms of bowel symptoms.
Strengths of this study include the prospective design and the use of validated instruments to
measure bowel symptoms. The multi-center study design also enhances generalizability of
the results. While not surprising in an older study population, the loss to follow-up at 1 year
(15%) was a limitation of the study, further limiting the power of subgroup comparisons.
Possible reasons for the 15% loss to follow-up may include greater burden of comorbid
conditions, worsening functional status, and even death.
Finally, although we demonstrated statistically significant changes in the CRADI and
CRAIQ scores after surgery, such changes may not always represent clinically significant
differences. The minimum important difference (MID; the smallest change in score
associated with a clinically meaningful change in a questionnaire) [12] was recently reported
for the urinary subscales of the PFDI and PFIQ, [13] but has not yet been reported for the
CRADI and CRAIQ. However, a change equivalent to an effect size of 0.5 (or score change
equal to half of the baseline score SD) may be used to approximate the MID, and this is
roughly what we observed for the CRADI composite and CRADI obstructive scale scores,
suggesting that the symptom improvement we observed is clinically significant. Further
research using these questionnaires is needed to better understand these differences.
In conclusion, individual bothersome bowel symptoms, including obstructive, incontinence,
and some pain/irritation symptoms, improve after colpocleisis, and the development of new
bothersome bowel symptoms is uncommon. Given the high prevalence of bothersome
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colorectal symptoms found in this cohort of women, our finding that the majority of these
symptoms resolve after colpocleisis is significant. These results should be useful to
clinicians in counseling patients planning colpocleisis for advanced POP.
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Table 1
Clinical and demographic characteristics of subjects with complete baseline and 1 year questionnaires (n=121)
Mean ± SD, n (%)
Age (years) 79.2±5.4
Body mass index (kg/m2) 27.8±5.2
Race
 Caucasian 110 (91%)
 African American 11 (9%)
Prior hysterectomy 73 (60%)
Prior prolapse surgery 28 (23%)
POP-Q
 Stage 3 72 (62%)
 Stage 4 45 (38%)
Type of colpocleisis
 Partial (LeFort) 74 (61%)
 Total 47 (39%)
Concomitant surgeries
 Levator myorrhaphy 86 (71%)
 Perineorrhaphy 117 (97%)
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Table 2
Prevalence of individual bowel symptoms before surgery and 1 year after surgery
Colorectal-anal distress inventory (individual bowel
symptoms)
Prevalence of bothersome






Digital assistance 20 (16.7%) 6 (5.0%) <0.01*
Straining 24 (20%) 7 (5.8%) <0.01*
Incomplete emptying 32 (26.5%) 8 (6.7%) <0.01*
Anal incontinence with stress 25 (20.7%) 13 (10.7%) 0.01*
Anal incontinence with urge 22 (18.2%) 11 (9.1%) 0.03*
Anal incontinence—solid 14 (11.6%) 9 (7.4%) 0.23
Anal incontinence—liquid 30 (24.8%) 13 (10.7%) <0.01*
Anal incontinence—flatus 42 (34.7%) 17 (14.1%) <0.01*
Low back pain 41 (33.9%) 32 (26.5%) 0.11
Pain prior to BM 8 (6.6%) 7 (5.8%) 0.78
Pain with defecation 5 (4.1%) 5 (4.1%) 1
Fecal urgency 22 (18.2%) 12 (9.9%) 0.03*
Mucus with BM 4 (3.3%) 0 (0%) 0.03*
Hemorrhoids 17 (14.1%) 4 (3.3%) <0.01*
Pain with straining 16 (13.2%) 19 (15.7%) 0.55
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Table 3
Combined bowel symptoms (CRADI composite and subscale scores and CRAIQ composite scores) before
surgery and 1 year after surgery
Bowel symptoms Preoperative (N=121) median (IQR) 1 year postoperative (N=121) median (IQR) p value
CRADI 55.2 (25.7, 101.4) 21.1 (3.6, 66.1) <0.01*
CRADI obstructive 16.7 (0, 41.7) 0 (0, 16.7) <0.01*
CRADI incontinence 20 (0, 40) 0 (0, 20) <0.01*
CRADI pain/irritation 14.3 (3.6, 25) 7.1 (0, 17.9) <0.01*

















Gutman et al. Page 10
Table 4




Subjects with bothersome symptom (score
>2) at baseline
Subjects with no bothersome symptom
(score ≤2) at baseline
N Resolution at 1year (score ≤2),
N(%)a
N De novo symptom at 1year (score
>2), N (%)b
Digital assistance 20 18 (90%) 101 4 (4%)
Straining 24 22 (91.7%) 97 5 (5.2%)
Incomplete emptying 32 27 (84.4%) 89 3 (3.4%)
Anal incontinence—stress 25 18 (72%) 96 6 (6.3%)
Anal incontinence—urge 22 19 (86.4%) 99 8 (8.1%)
Anal incontinence—solid 14 11 (78.6%) 107 6 (5.6%)
Anal incontinence—liquid 30 23 (76.7%) 91 6 (6.6%)
Anal incontinence—flatus 42 30 (71.4%) 79 5 (6.3%)
Low back pain 41 20 (48.8%) 80 11 (13.8%)
Pain prior to BM 8 7 (87.5%) 113 6 (5.3%)
Pain with defecation 5 5 (100%) 116 5 (4.3%)
Fecal urgency 22 15 (68.2%) 99 5 (5.1%)
Mucus with BM 4 4 (100%) 117 0 (0%)
Hemorrhoids 17 15 (88.2%) 104 2 (1.9%)
Pain with straining 16 11 (68.8%) 105 14 (13.3%)
Rectal prolapse 8 6 (75%) 113 4 (3.5%)
a
Percentage of resolution among all subjects who had bothersome symptom at baseline
b
Percentage of subjects with de novo bothersome symptom among all subjects who had no bothersome symptom at baseline
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